These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38415341)

  • 21. Cost-effectiveness analysis of antiviral therapies for hepatitis B e antigen-positive chronic hepatitis B patients in China.
    Zhang C; Ke W; Gao Y; Zhou S; Liu L; Ye X; Yao Z; Yang Y
    Clin Drug Investig; 2015 Mar; 35(3):197-209. PubMed ID: 25672930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission.
    Fang K; Li S; Lin Y; Zhang Y; Wu J
    BMC Public Health; 2024 Aug; 24(1):2202. PubMed ID: 39138480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
    Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
    J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
    World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region.
    Kim DY; Toan BN; Tan CK; Hasan I; Setiawan L; Yu ML; Izumi N; Huyen NN; Chow PK; Mohamed R; Chan SL; Tanwandee T; Lee TY; Hai TTN; Yang T; Lee WC; Chan HLY
    Clin Mol Hepatol; 2023 Apr; 29(2):277-292. PubMed ID: 36710606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma.
    Chen J; Tang D; Xu C; Niu Z; Li H; Li Y; Zhang P
    Lab Med; 2021 Jul; 52(4):381-389. PubMed ID: 33159511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-Effectiveness Comparison Between the Response-Guided Therapies and Monotherapies of Nucleos(t)ide Analogues for Chronic Hepatitis B Patients in China.
    Lai K; Zhang C; Ke W; Gao Y; Zhou S; Liu L; Yang Y
    Clin Drug Investig; 2017 Mar; 37(3):233-247. PubMed ID: 27928739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.
    Zhang P; Yang Y; Wen F; Wheeler J; Fu P; Li Q
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1978-1985. PubMed ID: 27118432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
    Wun YT; Dickinson JA
    Cochrane Database Syst Rev; 2003; (2):CD002799. PubMed ID: 12804438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis.
    Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Jackson S; Ryder S; Cramp M; Stein K
    Br J Cancer; 2008 Apr; 98(7):1166-75. PubMed ID: 18382459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis.
    Su TH; Peng CY; Chang SH; Tseng TC; Liu CJ; Chen CL; Liu CH; Yang HC; Chen PJ; Kao JH
    J Formos Med Assoc; 2022 Mar; 121(3):703-711. PubMed ID: 34452785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
    Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
    J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
    Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
    Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B.
    Kim HL; Kim GA; Park JA; Kang HR; Lee EK; Lim YS
    Gut; 2021 Nov; 70(11):2172-2182. PubMed ID: 33239344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Diagnostic Model for Early Hepatitis B Virus-Related Hepatocellular Carcinoma Diagnosis.
    Li S; Liu D; Wang Q
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
    Huang S; Jiang F; Wang Y; Yu Y; Ren S; Wang X; Yin P; Lou J
    Tumour Biol; 2017 Jun; 39(6):1010428317705763. PubMed ID: 28621228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommended 10-Year Follow-Up Strategy for Small Hepatocellular Carcinoma After Radiofrequency Ablation: A Cost-Effectiveness Evaluation.
    Chen QF; Chen S; Yi JZ; Wang JL; Zhong SX; Jiang XY; Hu Y; Tan GJ; Xu J; Lyu N; Zhao M
    Am J Gastroenterol; 2024 Oct; 119(10):2052-2060. PubMed ID: 38526213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.
    Jia Y; Li L; Cui F; Zhang D; Zhang G; Wang F; Gong X; Zheng H; Wu Z; Miao N; Sun X; Zhang L; Lv J; Yang F
    Hum Vaccin Immunother; 2014; 10(10):2983-91. PubMed ID: 25483678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of hepatitis E vaccination strategies among patients with chronic hepatitis B in China.
    Cui T; Zhang X; Wang Q; Yue N; Bao C; Jiang R; Xu S; Yuan Z; Qian Y; Chen L; Hang H; Zhang Z; Sun H; Jin H
    Hepatol Res; 2024 Feb; 54(2):142-150. PubMed ID: 37706554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.